HLA-DQ polymorphisms modify the risk of thyroid autoimmunity in children with type 1 diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 16, Issue 6, 2003, Pages 851-858

  Šumník, Zdeněk ^a   Drevinek P ^a   Snajderova M ^a   Kolouskova S ^a   Sedlakova P ^a   Pechova M ^b   Vavrinec J ^a   Cinek, O ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Children; HLA DQ polymorphism; Prevalence; Thyroid autoimmunity; Type 1 diabetes mellitus

Indexed keywords

AUTOANTIBODY; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CHILDHOOD DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HASHIMOTO DISEASE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; POLYMERASE CHAIN REACTION; PREVALENCE; RISK ASSESSMENT; SCREENING TEST; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL ANALYSIS;

EID: 18844482222     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2003.16.6.851     Document Type: Article

References (42)

1. Lorini R, d'Annunzio G, Vitali L, Scaramuzza A. IDDM and autoimmune thyroid disease in the pediatric age group. J Pediatr Endocrinol Metab 1996; 9: 89-94.
2. McKenna M, Herskowitz R, Wolfsdorf JI. Screening for thyroid disease in children with IDDM. Diabetes Care 1990; 13: 801-803.
3. Radetti G, Paganini C, Gentili L, Bernasconi S, Betterle C, Borkens L, Cvijovic K, Kadrnka-Lovrecic M, Krzisnik C, Battelino T. Frequency of Hashimoto's thyroiditis in children with type 1 diabetes mellitus. Acta Diabetol 1995; 32: 121-124.
4. Chikuba N, Akazawa S, Yamaguchi Y, Kawasaki E, Takino H, Takao Y, Maeda Y, Okuno S, Yamamoto H, Yokota A, Yoshimoto M, Nagataki S. Type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune thyroid disease in Japan. Intern Med 1992; 31: 1076-1080.
5. Cardoso C, Ohwovoriole AE, KuKu SF. A study of thyroid function and prevalence of thyroid autoantibodies in an African diabetic population. J Diabetes Complications 1995; 9: 37-41.
6. Kontikainen S, Schlenzka A, Koskimies S, Rilva A, Maenpaa J. Autoantibodies and autoimmune diseases in young diabetics. Diabetes Res 1990; 13: 151-156.
7. Riley WJ, MacLaren NK, Lezotte DC, Spillar R, Rosenbloom AL. Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr 1981; 98: 350-354.
8. Valerio G, Franzese A, Iovino A, Tanga M, Alessio M, Pignata C. Simultaneous peripubertal onset of multi-reactive autoimmune diseases with an unusual long-lasting remission of type 1 diabetes mellitus. Clin Endocrinol 2000; 53: 649-653.
9. Djilali-Saiah I, Bertin E, Larger E, Timsit J, Assan R, Boitard C, Bach JF, Caillat-Zucman S. Major histocompatibility class II Genes polymorphism in insulin dependent diabetes mellitus with or without associated thyroid autoimmunity. Hum Immunol 1998; 59: 176-182.
10. Tomer Y, Barbesino G, Greenberg D, Davies TF. The immunogenetics of autoimmune diabetes and autoimmune thyroid disease. Trends Endocrinol Metab 1997; 8: 63-70.
11. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993; 41: 119-134.
12. Fernandez-Soto T, Gonzales A, Lobon JA, Lopez JA, Peterson CM, Escobar-Jimenez F. Thyroid peroxidase autoantibodies predict poor metabolic control and the need of thyroid treatment in pregnant IDDM women. Diabetes Care 1997; 20: 1524-1528.
13. McCanlies E, O'Leary AL, Foley TP, Kramer MK, Burke JP, Libman A, Swan JS, Steenkiste AR, McCarthy BJ, Trucco M, Dorman JS. Hashimoto's thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J Clin Endocrinol Metab 1998; 83: 1548-1551.
14. Fernandez-Castaner M, Molina A, Lopez-Jimenez L, Gomez JM, Soler J. Clinical presentation and early course of type 1 diabetes in patients with and without thyroid autoimmunity. Diabetes Care 1999; 22: 377-381.
15. Hansen D, Bennedbaek FN, Hansen LK, Hoier-Madsen M, Jacobsen J, Hegedus L. Thyroid function, morphology and autoimmunity in young patients with insulin-dependent diabetes mellitus. Eur J Endocrinol 1999; 140: 512-518.
16. Thai AC, Ng WZ, Lui KF, Cheah JS. Islet cell and thyroid autoimmunity in Chinese patients with IDDM. Diabetes Care 1995; 18: 586-587.
17. Cerai LMP, Weber G, Meschi F, Mora S, Bognetti E, Siragusa V, Di Natale B. Prevalence of thyroid autoantibodies and thyroid autoimmune disease in diabetic children and adolescents. Diabetes Care 1994; 17: 782-783.
18. Holl RW, Böhm B, Loos U, Grabert M, Heinze E, Homoki J. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Horm Res 1999; 52: 113-118.
19. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335: 99-107.
20. Lindberg B, Carlsson A, Ericsson UB, Kockum I, Lernmark A, Landin-Olsson M, Sundkvist G, Ivarsson SA. Prevalence of beta-cell and thyroid autoantibody positivity in schoolchildren during three-year follow-up. Autoimmunity 1999; 31: 175-185.
21. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Rodgers H, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995; 43: 55-68.
22. Schumm-Draeger PM, Padberg S, Heller K. Prophylactic levothyroxine therapy in patients with Hashimoto's thyroiditis. Exp Clin Endocrinol Diabetes 1999; 107 (Suppl 3): S84-S87.
23. Skiner GRB, Thomas R, Taylor M, Sellarajah M, Bolt S, Krett S, Wright A. Thyroxine should be tried in clinically hypothyroid but biochemically euthyroid patients. BMJ 1997; 413: 1764.
24. Padberg S, Heller K, Usadel KH, Schumm-Draeger PM. One-year prophylactic treatment of euthyroid Hashimoto's thyroiditis patients with levothyroxine: Is there a benefit? Thyroid 2001; 11: 249-255.
25. Linstedt G, Eggertsen R, Sundbeck G, Eden S, Nystrom E. Thyroid dysfunction and chronic fatigue. Lancet 2001; 358: 151.
26. Gough SC. The genetics of Graves' disease. Endocrinol Metab Clin North Am 2000;29: 255-266.
27. Roman SH, Davies TF, Witt ME, Ginsberg-Fellner F, Rubinstein P. Thyroid autoantibodies in HLA-genotyped type 1 diabetic families: sex-limited DR5 association with thyroid microsomal antibody. Clin Endocrinol 1986; 25: 23-33.
28. Shi Y, Zou M, Robb D, Farid NR Typing for major histocompatibility complex class II antigens in thyroid tissue blocks: association of Hashimoto's thyroiditis with HLA-DQA0301 and DQB0201 alleles. J Clin Endocrinol Metab 1992; 75: 943-946.
29. Tandon N, Zhang L, Weetman AP. HLA associations with Hashimoto's thyroiditis. Clin Endocrinol 1991; 34: 383-386.
30. Tamai H, Kimura A, Dong RP, Matsubayashi S, Kuma K, Nagataki S, Sasazuki T. Resistance to autoimmune thyroid disease is associated with HLA-DQ. J Clin Endocrinol Metab 1994; 78: 94-97.
31. Barbesino G, Chiovato L. The genetics of Hashimoto's disease. Endocrinol Metab Clin North Am 2000; 29: 357-374.
32. Thompson C, Farid NR. Post-partum thyroiditis and goitrous (Hashimoto's) thyroiditis are associated with HLA-DR4. Immunol Lett 1985; 11: 301-303.
33. Caillat-Zuckman S, Djilali-Saiah I, Timsit J, Bonifacio E, Sepe V, Collins P, Botazzo GF, Maclaren N, Delamaire M, Martin S, Yamamoto AM, McWeeney S, Valdes AM, Babron MC, Thorsby E, Clerget-Darpoux F, Thomson G, Bach JF. Insulin dependent diabetes mellitus (IDDM): 12th International Histocompatibility Workshop study. 12th International HLA Workshop, Paris, 1997; 389-398.
34. Nejentsev S, Reijonen H, Adojaan B, Kovalchuk L, Sochnevs A, Schwartz El, Åkerblom HK, Ilonen J. The effect of HLA-B allele on the IDDM risk defined by DRB1z.ast;04 Subtypes and DQB1*0302. Diabetes 1997; 46: 1888-1892.
35. Undlien DE, Friede T, Rammensee HG, Joner G, Dahl-Jorgensen K, Sovik O, Akelsen HE, Knutsen I, Ronningen KS, Thorsby E. HLA-encoded genetic pre-disposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes 1997; 46: 143-149.
36. Moghaddam HP, de Knijf P, Roep BO, Van der Auwera B, Naipal A, Gorus F, Schuit F, Giphart MJ. Genetic structure of IDDM1: two separate regions in the major histocompatibility complex contribute to susceptibility or protection. Belgian Diabetes Registry. Diabetes 1998; 47: 263-269.
37. Lie BA, Todd JA, Pociot F, Nerup J, Akselsen HE, Joner G, Dahl-Jorgensen K, Ronningen KS, Thorsby E, Undlien DE. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet 1999; 64: 793-800.
38. Cinek O, Koloušková S, Šnajderová M, Šumnik Z, Sedláková P, Dřevínek P, Vavŕinec J. HLA class II genetic association of type 1 diabetes mellitus in Czech children. Pediatr Diabetes 2001; 2: 98-102.
39. Santamaria P, Barbosa JJ, Lindstrom AL, Lemke TA, Goetz FC, Rich SS. HLA-DQB1-associated susceptibility that distinguishes Hashimoto's thyroiditis from Graves' disease in type I diabetic patients. J Clin Endocrinol Metab 1994; 78: 878-883.
40. Chuang LM, Wu HP, Chang CC, Tsai WY, Chang HM, Tai TZ, Lin BJ. HLA DRB1/DQA1/DQB1 haplotype determines thyroid autoimmunity in patients with insulin-dependent diabetes mellitus. Clin Endocrinol 1996; 45: 631-636.
41. Abrams P, DeLeeuw I, Vertommen J, The Belgian Diabetes Registry. In new-onset insulin-dependent diabetic patients the presence of antithyroid peroxidase antibodies is associated with islet cell autoimmunity and the high risk haplotype HLA DQA1*0301-DQB1*0302. Diabet Med 1995; 13: 415-419.
42. Sabbah E, Savola K, Ebeling T, Kulmala P, Vasahalo P, Ilonen J, Salmela PI, Knip M. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 2000; 23: 1326-1332.